Does ANIFROLUMAB Cause Product dose omission issue? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Product dose omission issue have been filed in association with ANIFROLUMAB (SAPHNELO). This represents 3.2% of all adverse event reports for ANIFROLUMAB.
12
Reports of Product dose omission issue with ANIFROLUMAB
3.2%
of all ANIFROLUMAB reports
0
Deaths
6
Hospitalizations
How Dangerous Is Product dose omission issue From ANIFROLUMAB?
Of the 12 reports, 6 (50.0%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ANIFROLUMAB. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does ANIFROLUMAB Cause?
Off label use (33)
Systemic lupus erythematosus (31)
Drug ineffective (26)
Fatigue (19)
Arthralgia (18)
Pyrexia (18)
Covid-19 (17)
Cough (16)
Headache (16)
Lupus nephritis (16)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which ANIFROLUMAB Alternatives Have Lower Product dose omission issue Risk?
ANIFROLUMAB vs ANIFROLUMAB-FNIA
ANIFROLUMAB vs ANIFROLUMAB\ANIFROLUMAB-FNIA
ANIFROLUMAB vs ANTHOXANTHUM ODORATUM POLLEN\DACTYLIS GLOMERATA POLLEN\LOLIUM PERENNE POLLEN\PHLEUM PRATENSE POLLEN\POA PRATENSIS POLLEN
ANIFROLUMAB vs ANTI-INHIBITOR COAGULANT COMPLEX
ANIFROLUMAB vs ANTIHEMOPHILIC FACTOR HUMAN